To examine the effects of psychoeducational (health education and stress management) programmes for coronary heart disease (CHD) patients.
Success was defined as significant favourable results on all proximal targets measured in the study. When both significant and non significant results were achieved, the study was considered to have partial success and when no significant or unfavourable results were achieved, the study was considered as having failed.
How were decisions on the relevance of primary studies made?
The authors do not state how the papers were selected for the review, or how many of the reviewers performed the selection.
Assessment of study quality
Validity was not formally assessed though aspects of validity including validity of measurement tool, features of randomisation, study design, and quality of data were coded and discussed. Two independent raters coded study features. Any disagreements were resolved by a third rater.
Data extraction
The following data were extracted and coded by two independent raters: type of intervention; year of publication; study design; country; patient inclusion and exclusion criteria; setting; measurement point; length of programme; profession of programme providers; target of treatment; and five indicators of programme quality (see Other Publications of Related Interest no.1). Computation of effect sizes and outcomes were also coded. Disagreements were resolved by a third rater. When multiple comparisons were reported, only one comparison was selected from each study.
A population effect size was calculated for each outcome variable and expressed as a standardized mean difference (Cohen's d) by converting the weighted average effect size (WAES) r (see Other Publications of Related Interest no.2). Population effect size with the adjusted post-test effect size was estimated for the dependent variables with a pre-test measurement.
Methods of synthesis
How were the studies combined? Comprehensive details of the statistical analyses were reported. Only summary details are mentioned here. Pooled mortality and morbidity rates were estimated using the random effects Mantel-Haenszel summary estimate of the odds ratio (OR).
How were differences between studies investigated?
Effect sizes were considered to be homogeneous if the following two conditions were satisfied: the percentage of observed variance accounted for by sampling error was at least 75% and the chi-squared test for heterogeneity was not significant. In cases of heterogeneity moderators were sought where more than five studies were used for the summary estimate. Disjoint cluster analysis was used to identify possible clusters of similar effect sizes. The influence of study features on the effect sizes was also examined. A study feature was considered to be a moderator if its categories identified distinct homogeneous sets of study effect sizes.
Results of the review
Thirty-seven studies were included (9081 participants). Studies included 28 RCTs and 9 quasi randomised studies.
Only some of the many results presented in the review are reported here.
Most studies evaluated the effect of a health education and stress management programme. On average, the pretest measurement occurred four weeks after the cardiac event. The programs varied substantially in duration and number of sessions.
Methodological problems in the primary studies included absence of clear descriptions of intervention programs and program components and poor quality of measurements of risk factors and related behaviours. The distribution of effect sizes for the total measurement period did not suggest a homogeneous set of studies.
Cardiac mortality (10 studies, 4266 patients): Total measurement period ranged from 6 months to 10 years. Population effect size was significant for the long term and for the part/success cluster. Heterogeneity was found. Studies without success on proximal factors were homogeneous and studies with success/partial success on proximal factors were homogeneous.
Total WAES (weighted average effect size) r = 0.23 (95% CI: -0.008, -0.053). OR = 1.30.
MI recurrence (16 studies, 7084 patients): Total measurement period ranged from 1 to 10 years. Population effect size was significant at all measurement periods except for short term. Heterogeneity was found. Studies without success on proximal factors were homogeneous and studies with success/partial success on proximal factors with more than 100 patients were homogeneous. Population effect sizes were significant only for the success cluster.
Total WAES r = 0.032 (95% CI: 0.008, 0.055). OR = 1.25.
CABG and angina pectoris: estimated population effect size was significant only for the short-term for angina pectoris. Short term WAES r for angina pectoris = 0.036 (95% CI: 0.002, 0.069). OR =1.16.
Risk factors and psychological variables:
Mean systolic blood pressure (7 studies): For total period and medium term interventions were associated with decreased blood pressure (BP).
Total serum cholesterol (7 studies): at all measurement times rehabilitated patients showed reduced cholesterol. However heterogeneity was found and no moderators were identified. Smoking behaviour (21 studies): at total measurement and for medium term, rehabilitated patients showed an increase in those stopping smoking. At each measurement period studies were heterogeneous.
Physical exercise (8 studies), healthy eating habits (6 studies): the quality of measurement was low and no single indicator could be determined. At all measurement times, heterogeneity was found.
Anxiety (10 studies): all but one used a validated questionnaire. Depression (13 studies): all but 2 studies used a validated questionnaire.
All sets of study effect sizes were homogeneous. There was no evidence that the interventions reduced anxiety or depression.
Three study features were found to act as moderators: success on proximal targets; quality of data; and year of publication. The following were not found to act as moderators: features of random assignment; program characteristics (type of evaluation, setting, program length, profession of provider, individual or group treatment, participation of partners); and patient characteristics (mean age, type of cardiac event, % women).
